TreeWAS – Variant ID: rs850892

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K70-K77 Diseases of liver	0.394	0.606	0.000
K74 Fibrosis and cirrhosis of liver	0.387	0.613	0.000
K75 Other inflammatory liver diseases	0.383	0.617	0.000
K74.6 Other and unspecified cirrhosis of liver	0.378	0.622	0.000
K76 Other diseases of liver	0.378	0.622	0.000
K75.8 Other specified inflammatory liver diseases	0.368	0.632	0.000
K70 Alcoholic liver disease	0.357	0.643	0.000
K76.6 Portal hypertension	0.347	0.653	0.000
K73 Chronic hepatitis, not elsewhere classified	0.347	0.653	0.000
K74.0 Hepatic fibrosis	0.342	0.658	0.000
K75.4 Autoimmune hepatitis	0.330	0.670	0.000
K76.0 Fatty (change of) liver, not elsewhere classified	0.324	0.676	0.000
K70.1 Alcoholic hepatitis	0.319	0.681	0.000
K77 Liver disorders in diseases classified elsewhere	0.318	0.682	0.000
K70.3 Alcoholic cirrhosis of liver	0.316	0.684	0.000
K70.4 Alcoholic hepatic failure	0.316	0.684	0.000
K76.8 Other specified diseases of liver	0.315	0.685	0.000
K75.9 Inflammatory liver disease, unspecified	0.310	0.690	0.000
K74.1 Hepatic sclerosis	0.309	0.691	0.000
K73.2 Chronic active hepatitis, not elsewhere classified	0.307	0.693	0.000
K76.3 Infarction of liver	0.295	0.705	0.000
K75.3 Granulomatous hepatitis, not elsewhere classified	0.286	0.714	0.000
K76.1 Chronic passive congestion of liver	0.284	0.716	0.000
K74.4 Secondary biliary cirrhosis	0.277	0.722	0.000
K74.2 Hepatic fibrosis with hepatic sclerosis	0.277	0.722	0.000
K75.2 Nonspecific reactive hepatitis	0.275	0.725	0.000
K75.1 Phlebitis of portal vein	0.275	0.725	0.000
K73.8 Other chronic hepatitis, not elsewhere classified	0.272	0.728	0.000
K76.5 Hepatic veno-occlusive disease	0.271	0.729	0.000
K76.4 Peliosis hepatis	0.271	0.729	0.000
K76.2 Central haemorrhagic necrosis of liver	0.271	0.729	0.000
K77.8 Liver disorders in other diseases classified elsewhere	0.264	0.736	0.000
K72 Hepatic failure, not elsewhere classified	0.263	0.737	0.000
K73.1 Chronic lobular hepatitis, not elsewhere classified	0.249	0.751	0.000
K73.0 Chronic persistent hepatitis, not elsewhere classified	0.249	0.751	0.000
K71 Toxic liver disease	0.248	0.752	0.000
K76.7 Hepatorenal syndrome	0.246	0.754	0.000
K74.5 Biliary cirrhosis, unspecified	0.242	0.758	0.000
K73.9 Chronic hepatitis, unspecified	0.237	0.763	0.000
K70.2 Alcoholic fibrosis and sclerosis of liver	0.233	0.767	0.000
K77.0 Liver disorders in infectious and parasitic diseases classified elsewhere	0.228	0.772	0.000
K70.0 Alcoholic fatty liver	0.215	0.785	0.000
K74.3 Primary biliary cirrhosis	0.211	0.789	0.000
K76.9 Liver disease, unspecified	0.206	0.794	0.000
K72.0 Acute and subacute hepatic failure	0.203	0.797	0.000
K72.1 Chronic hepatic failure	0.178	0.821	0.000
K71.9 Toxic liver disease, unspecified	0.178	0.822	0.000
K71.8 Toxic liver disease with other disorders of liver	0.178	0.822	0.000
K71.7 Toxic liver disease with fibrosis and cirrhosis of liver	0.178	0.822	0.000
K71.5 Toxic liver disease with chronic active hepatitis	0.178	0.822	0.000
K71.4 Toxic liver disease with chronic lobular hepatitis	0.178	0.822	0.000
K71.3 Toxic liver disease with chronic persistent hepatitis	0.178	0.822	0.000
K71.2 Toxic liver disease with acute hepatitis	0.178	0.822	0.000
K71.1 Toxic liver disease with hepatic necrosis	0.174	0.826	0.000
K75.0 Abscess of liver	0.169	0.831	0.000
K71.6 Toxic liver disease with hepatitis, not elsewhere classified	0.167	0.832	0.000
K71.0 Toxic liver disease with cholestasis	0.160	0.839	0.000
K72.9 Hepatic failure, unspecified	0.160	0.840	0.000
K70.9 Alcoholic liver disease, unspecified	0.122	0.878	0.000
C90.0 Multiple myeloma	0.029	0.971	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.026	0.974	0.000
E80.4 Gilbert's syndrome	0.026	0.974	0.000
C90.1 Plasma cell leukaemia	0.023	0.977	0.000
C90.3 Solitary plasmacytoma	0.022	0.978	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.020	0.980	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.019	0.981	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.019	0.981	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.018	0.982	0.000
C90.2 Plasmacytoma, extramedullary	0.018	0.982	0.000
C83.3 Large cell (diffuse)	0.017	0.983	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.016	0.984	0.000
C88 Malignant immunoproliferative diseases	0.016	0.984	0.000
C81 Hodgkin's disease	0.016	0.984	0.000
C83.0 Small cell (diffuse)	0.016	0.984	0.000
U80.1 Methicillin resistant agent	0.015	0.985	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.015	0.985	0.000
C95 Leukaemia of unspecified cell type	0.014	0.986	0.000
C83.5 Lymphoblastic (diffuse)	0.014	0.986	0.000
C94 Other leukaemias of specified cell type	0.014	0.986	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.014	0.986	0.000
C82.6 Cutaneous follicle centre lymphoma	0.013	0.986	0.000
C82.5 Diffuse follicle centre lymphoma	0.013	0.986	0.000
C82.3 Follicular lymphoma grade IIIa	0.013	0.987	0.000
E80 Disorders of porphyrin and bilirubin metabolism	0.013	0.987	0.000
C82.0 Small cleaved cell, follicular	0.013	0.987	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.013	0.987	0.000
C83.6 Undifferentiated (diffuse)	0.013	0.987	0.000
C83.4 Immunoblastic (diffuse)	0.013	0.987	0.000
C83.2 Mixed small and large cell (diffuse)	0.013	0.987	0.000
F60.3 Emotionally unstable personality disorder	0.013	0.987	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.013	0.987	0.000
C81.0 Lymphocytic predominance	0.013	0.987	0.000
C93 Monocytic leukaemia	0.013	0.987	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.013	0.987	0.000
C81.2 Mixed cellularity	0.013	0.987	0.000
C86 Other specified types of T/NK-cell lymphoma	0.012	0.988	0.000
C83.7 Burkitt's tumour	0.012	0.988	0.000
M06.96 Rheumatoid arthritis, unspecified (Lower leg)	0.000	0.988	0.012
C81.7 Other Hodgkin's disease	0.012	0.988	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.012	0.988	0.000
C88.7 Other malignant immunoproliferative diseases	0.012	0.988	0.000
C88.3 Immunoproliferative small intestinal disease	0.012	0.988	0.000
C88.2 Gamma heavy chain disease	0.012	0.988	0.000
C88.1 Alpha heavy chain disease	0.012	0.988	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.012	0.988	0.000
C81.1 Nodular sclerosis	0.012	0.988	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.012	0.988	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.012	0.988	0.000
C81.3 Lymphocytic depletion	0.012	0.988	0.000
C81.9 Hodgkin's disease, unspecified	0.012	0.988	0.000
F60 Specific personality disorders	0.012	0.988	0.000
O82.1 Delivery by emergency Caesarean section	0.012	0.988	0.000
C95.9 Leukaemia, unspecified	0.011	0.988	0.000
Z36.8 Other antenatal screening	0.011	0.989	0.000
C82.4 Follicular lymphoma grade IIIb	0.011	0.989	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.011	0.989	0.000
C83.1 Small cleaved cell (diffuse)	0.011	0.989	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.011	0.989	0.000
F60.9 Personality disorder, unspecified	0.011	0.989	0.000
C82.2 Large cell, follicular	0.011	0.989	0.000
E80.7 Disorder of bilirubin metabolism, unspecified	0.011	0.989	0.000
C95.7 Other leukaemia of unspecified cell type	0.010	0.989	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.010	0.989	0.000
C94.4 Acute panmyelosis	0.010	0.990	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.010	0.990	0.000
E80.2 Other porphyria	0.010	0.990	0.000
C94.7 Other specified leukaemias	0.010	0.990	0.000
C94.5 Acute myelofibrosis	0.010	0.990	0.000
C94.3 Mast cell leukaemia	0.010	0.990	0.000
C94.2 Acute megakaryoblastic leukaemia	0.010	0.990	0.000
C94.1 Chronic erythraemia	0.010	0.990	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.010	0.990	0.000
C95.0 Acute leukaemia of unspecified cell type	0.010	0.990	0.000
E80.6 Other disorders of bilirubin metabolism	0.010	0.990	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.010	0.990	0.000
C96.8 Histiocytic sarcoma	0.010	0.990	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.010	0.990	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.010	0.990	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.010	0.990	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.010	0.990	0.000
C96.3 True histiocytic lymphoma	0.010	0.990	0.000
C96.2 Malignant mast cell tumour	0.010	0.990	0.000
C96.1 Malignant histiocytosis	0.010	0.990	0.000
C96.0 Letterer-Siwe disease	0.010	0.990	0.000
D18.0 Haemangioma, any site	0.010	0.990	0.000
E80.5 Crigler-Najjar syndrome	0.010	0.990	0.000
E80.3 Defects of catalase and peroxydase	0.010	0.990	0.000
E80.0 Hereditary erythropoietic porphyria	0.010	0.990	0.000
E80.1 Porphyria cutanea tarda	0.010	0.990	0.000
F60.5 Anankastic personality disorder	0.010	0.990	0.000
Z36 Antenatal screening	0.010	0.990	0.000
C93.9 Monocytic leukaemia, unspecified	0.009	0.991	0.000
C93.7 Other monocytic leukaemia	0.009	0.991	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.009	0.991	0.000
C93.2 Subacute monocytic leukaemia	0.009	0.991	0.000
C93.0 Acute monocytic leukaemia	0.009	0.991	0.000
Z36.3 Antenatal screening for malformations using ultrasound and other physical methods	0.009	0.991	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.009	0.991	0.000
C86.4 Blastic NK-cell lymphoma	0.009	0.991	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.009	0.991	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.009	0.991	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.009	0.991	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.009	0.991	0.000
F60.8 Other specific personality disorders	0.009	0.991	0.000
C78.2 Secondary malignant neoplasm of pleura	0.009	0.991	0.000
F60.0 Paranoid personality disorder	0.009	0.991	0.000
Z36.0 Antenatal screening for chromosomal anomalies	0.009	0.991	0.000
C85.0 Lymphosarcoma	0.009	0.991	0.000
F60.4 Histrionic personality disorder	0.008	0.991	0.000
F60.1 Schizoid personality disorder	0.008	0.991	0.000
F60.2 Dissocial personality disorder	0.008	0.991	0.000
C93.1 Chronic monocytic leukaemia	0.008	0.991	0.000
O82 Single delivery by Caesarean section	0.009	0.991	0.000
H26.8 Other specified cataract	0.008	0.992	0.000
F60.6 Anxious [avoidant] personality disorder	0.008	0.992	0.000
F60.7 Dependent personality disorder	0.008	0.992	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.008	0.992	0.000
O82.0 Delivery by elective Caesarean section	0.008	0.992	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.008	0.992	0.000
Z36.4 Antenatal screening for foetal growth retardation using ultrasound and other physical methods	0.008	0.992	0.000
Z36.1 Antenatal screening for raised alphafetoprotein level	0.007	0.992	0.000
C92 Myeloid leukaemia	0.007	0.993	0.000
Z36.5 Antenatal screening for isoimmunisation	0.007	0.993	0.000
O82.9 Delivery by Caesarean section, unspecified	0.007	0.993	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.007	0.993	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.006	0.993	0.000
O82.8 Other single delivery by Caesarean section	0.006	0.994	0.000
O82.2 Delivery by Caesarean hysterectomy	0.006	0.994	0.000
C85.1 B-cell lymphoma, unspecified	0.006	0.994	0.000
F60-F69 Disorders of adult personality and behaviour	0.006	0.994	0.000
C92.5 Acute myelomonocytic leukaemia	0.006	0.994	0.000
M23.30 Other meniscus derangements (Multiple sites)	0.000	0.994	0.006
F69 Unspecified disorder of adult personality and behaviour	0.006	0.994	0.000
H43.8 Other disorders of vitreous body	0.006	0.994	0.000
C92.4 Acute promyelocytic leukaemia	0.006	0.994	0.000
Z36.9 Antenatal screening, unspecified	0.006	0.994	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.005	0.994	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.005	0.994	0.000
C92.3 Myeloid sarcoma	0.005	0.994	0.000
C92.2 Subacute myeloid leukaemia	0.005	0.994	0.000
Z36.2 Other antenatal screening based on amniocentesis	0.005	0.994	0.000
C92.9 Myeloid leukaemia, unspecified	0.005	0.995	0.000
H00.1 Chalazion	0.000	0.995	0.005
H27.0 Aphakia	0.005	0.995	0.000
C91 Lymphoid leukaemia	0.005	0.995	0.000
U80 Agent resistant to penicillin and related antibiotics	0.005	0.995	0.000
F61 Mixed and other personality disorders	0.005	0.995	0.000
C92.7 Other myeloid leukaemia	0.005	0.995	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.005	0.995	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.005	0.995	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.005	0.995	0.000
C84.3 Lymphoepithelioid lymphoma	0.005	0.995	0.000
C84.2 T-zone lymphoma	0.005	0.995	0.000
C84.1 Sezary's diease	0.005	0.995	0.000
H80.9 Otosclerosis, unspecified	0.005	0.995	0.000
F68 Other disorders of adult personality and behaviour	0.005	0.995	0.000
H27.8 Other specified disorders of lens	0.005	0.995	0.000
F66 Psychological and behavioural disorders associated with sexual development and orientation	0.005	0.995	0.000
F65 Disorders of sexual preference	0.005	0.995	0.000
F63 Habit and impulse disorders	0.005	0.995	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.004	0.995	0.000
S89.9 Unspecified injury of lower leg	0.005	0.995	0.000
Q24.5 Malformation of coronary vessels	0.005	0.995	0.000
J39.2 Other diseases of pharynx	0.005	0.995	0.000
F62 Enduring personality changes, not attributable to brain damage and disease	0.004	0.996	0.000
H27 Other disorders of lens	0.004	0.996	0.000
C84.0 Mycosis fungoides	0.004	0.996	0.001
R04.2 Haemoptysis	0.000	0.996	0.004
C91.8 Mature B-cell leukaemia Burkitt-type	0.004	0.996	0.000
C91.7 Other lymphoid leukaemia	0.004	0.996	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.004	0.996	0.000
C91.3 Prolymphocytic leukaemia	0.004	0.996	0.000
C91.2 Subacute lymphocytic leukaemia	0.004	0.996	0.000
N19 Unspecified renal failure	0.004	0.996	0.000
H53.8 Other visual disturbances	0.004	0.996	0.000
F64 Gender identity disorders	0.004	0.996	0.000
Q24.8 Other specified congenital malformations of heart	0.004	0.996	0.000
Q24 Other congenital malformations of heart	0.004	0.996	0.000
C91.5 Adult T-cell leukaemia	0.004	0.996	0.000
F68.8 Other specified disorders of adult personality and behaviour	0.003	0.996	0.000
F68.1 Intentional production or feigning of symptoms or disabilities, either physical or psychological [factitious disorder]	0.004	0.996	0.000
F68.0 Elaboration of physical symptoms for psychological reasons	0.003	0.996	0.000
C91.9 Lymphoid leukaemia, unspecified	0.004	0.996	0.000
F63.9 Habit and impulse disorder, unspecified	0.003	0.996	0.000
F63.8 Other habit and impulse disorders	0.003	0.996	0.000
F63.3 Trichotillomania	0.003	0.996	0.000
F63.2 Pathological stealing [kleptomania]	0.003	0.996	0.000
F63.1 Pathological fire-setting [pyromania]	0.003	0.996	0.000
F63.0 Pathological gambling	0.003	0.996	0.000
F65.9 Disorder of sexual preference, unspecified	0.003	0.996	0.000
F65.8 Other disorders of sexual preference	0.003	0.996	0.000
F65.6 Multiple disorders of sexual preference	0.003	0.996	0.000
F65.5 Sadomasochism	0.003	0.996	0.000
F65.4 Paedophilia	0.003	0.996	0.000
F65.3 Voyeurism	0.003	0.996	0.000
F65.2 Exhibitionism	0.003	0.996	0.000
F65.1 Fetishistic transvestism	0.003	0.996	0.000
F65.0 Fetishism	0.003	0.996	0.000
F66.9 Psychosexual development disorder, unspecified	0.003	0.996	0.000
F66.8 Other psychosexual development disorders	0.003	0.996	0.000
F66.2 Sexual relationship disorder	0.003	0.996	0.000
F66.1 Egodystonic sexual orientation	0.003	0.996	0.000
F66.0 Sexual maturation disorder	0.003	0.996	0.000
M41.96 Scoliosis, unspecified (Lumbar region)	0.004	0.996	0.000
C84.4 Peripheral T-cell lymphoma	0.003	0.996	0.001
C91.4 Hairy-cell leukaemia	0.004	0.996	0.000
L50.9 Urticaria, unspecified	0.004	0.996	0.000
K29.0 Acute haemorrhagic gastritis	0.000	0.996	0.004
D18 Haemangioma and lymphangioma, any site	0.003	0.996	0.000
Q24.9 Congenital malformation of the heart, unspecified	0.003	0.996	0.000
F62.8 Other enduring personality changes	0.003	0.997	0.000
F62.1 Enduring personality change after psychiatric illness	0.003	0.997	0.000
F62.0 Enduring personality change after catastrophic experience	0.003	0.997	0.000
H27.9 Disorder of lens, unspecified	0.003	0.997	0.000
H27.1 Dislocation of lens	0.003	0.997	0.000
C84.5 Other and unspecified T-cell lymphomas	0.003	0.997	0.001
C91.0 Acute lymphoblastic leukaemia	0.003	0.997	0.000
F52.2 Failure of genital response	0.003	0.997	0.000
U80.8 Agent resistant to other penicillin-related antibiotic	0.003	0.997	0.000
C92.1 Chronic myeloid leukaemia	0.003	0.997	0.000
U80.0 Penicillin resistant agent	0.003	0.997	0.000
Z71.1 Person with feared complaint in whom no diagnosis is made	0.000	0.997	0.003
F64.9 Gender identity disorder, unspecified	0.003	0.997	0.000
F64.8 Other gender identity disorders	0.003	0.997	0.000
F64.2 Gender identity disorder of childhood	0.003	0.997	0.000
F64.1 Dual-role transvestism	0.003	0.997	0.000
F62.9 Enduring personality change, unspecified	0.003	0.997	0.000
G96.0 Cerebrospinal fluid leak	0.003	0.997	0.000
Q24.0 Dextrocardia	0.003	0.997	0.000
Q24.6 Congenital heart block	0.003	0.997	0.000
Q24.3 Pulmonary infundibular stenosis	0.003	0.997	0.000
Q24.2 Cor triatriatum	0.003	0.997	0.000
Q24.1 Levocardia	0.003	0.997	0.000
Q24.4 Congenital subaortic stenosis	0.003	0.997	0.000
M21.57 Acquired clawhand, clubhand, clawfoot and clubfoot (Ankle and foot)	0.003	0.997	0.000
H80 Otosclerosis	0.003	0.997	0.000
Z43.3 Attention to colostomy	0.003	0.997	0.000
C92.0 Acute myeloid leukaemia	0.003	0.997	0.000
M77.12 Lateral epicondylitis (Upper arm)	0.003	0.997	0.000
H43 Disorders of vitreous body	0.003	0.997	0.000
K31.5 Obstruction of duodenum	0.003	0.997	0.000
H43.1 Vitreous haemorrhage	0.003	0.997	0.000
R27.0 Ataxia, unspecified	0.000	0.997	0.003
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.003	0.997	0.000
S81.8 Open wound of other parts of lower leg	0.000	0.998	0.002
O80-O84 Delivery	0.002	0.998	0.000
R25.2 Cramp and spasm	0.002	0.998	0.000
Z84.8 Family history of other specified conditions	0.000	0.998	0.002
N85.0 Endometrial glandular hyperplasia	0.002	0.998	0.000
O42.1 Premature rupture of membranes, onset of labour after 24 hours	0.000	0.998	0.002
M79.87 Other specified soft tissue disorders (Ankle and foot)	0.000	0.998	0.002
D18.1 Lymphangioma, any site	0.002	0.998	0.000
K22.6 Gastro-oesophageal laceration-haemorrhage syndrome	0.002	0.998	0.000
M19.09 Primary arthrosis of other joints (Site unspecified)	0.000	0.998	0.002
H80.0 Otosclerosis involving oval window, nonobliterative	0.002	0.998	0.000
F64.0 Transsexualism	0.002	0.998	0.001
H80.8 Other otosclerosis	0.002	0.998	0.000
H80.2 Cochlear otosclerosis	0.002	0.998	0.000
H80.1 Otosclerosis involving oval window, obliterative	0.002	0.998	0.000
D62 Acute posthaemorrhagic anaemia	0.000	0.998	0.002
S51.8 Open wound of other parts of forearm	0.000	0.998	0.002
O83 Other assisted single delivery	0.002	0.998	0.000
S52.51 Fracture of lower end of radius (open)	0.002	0.998	0.000
O81 Single delivery by forceps and vacuum extractor	0.002	0.998	0.000
K58.0 Irritable bowel syndrome with diarrhoea	0.000	0.998	0.002
R29.8 Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems	0.002	0.998	0.000
H43.9 Disorder of vitreous body, unspecified	0.002	0.998	0.000
O84 Multiple delivery	0.002	0.998	0.000
S89 Other and unspecified injuries of lower leg	0.002	0.998	0.000
O81.0 Low forceps delivery	0.002	0.998	0.000
H43.2 Crystalline deposits in vitreous body	0.002	0.998	0.000
M62.80 Other specified disorders of muscle (Multiple sites)	0.000	0.998	0.002
T83.6 Infection and inflammatory reaction due to prosthetic device, implant and graft in genital tract	0.002	0.998	0.000
H58.8 Visual disturbances in diseases classified elsewhere	0.000	0.998	0.002
H43.0 Vitreous prolapse	0.002	0.998	0.000
C22.0 Liver cell carcinoma	0.002	0.998	0.000
O83.1 Other assisted breech delivery	0.002	0.998	0.000
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.002	0.998	0.000
M77.1 Lateral epicondylitis	0.002	0.998	0.000
O83.9 Assisted single delivery, unspecified	0.002	0.998	0.000
O83.8 Other specified assisted single delivery	0.002	0.998	0.000
O83.4 Destructive operation for delivery	0.002	0.998	0.000
O83.3 Delivery of viable foetus in abdominal pregnancy	0.002	0.998	0.000
O83.2 Other manipulation-assisted delivery	0.002	0.998	0.000
O83.0 Breech extraction	0.002	0.998	0.000
O81.5 Delivery by combination of forceps and vacuum extractor	0.002	0.998	0.000
O81.2 Mid-cavity forceps with rotation	0.002	0.998	0.000
O81.1 Mid-cavity forceps delivery	0.002	0.998	0.000
F52 Sexual dysfunction, not caused by organic disorder or disease	0.002	0.998	0.000
O81.4 Vacuum extractor delivery	0.002	0.998	0.000
S63.4 Traumatic rupture of ligament of finger at metacarpophalangeal and interphalangeal joint(s)	0.000	0.998	0.002
D10.0 Lip	0.000	0.998	0.002
O84.9 Multiple delivery, unspecified	0.002	0.998	0.000
O84.8 Other multiple delivery	0.002	0.998	0.000
O84.2 Multiple delivery, all by Caesarean section	0.002	0.998	0.000
O84.1 Multiple delivery, all by forceps and vacuum extractor	0.002	0.998	0.000
O84.0 Multiple delivery, all spontaneous	0.002	0.998	0.000
S89.7 Multiple injuries of lower leg	0.002	0.998	0.000
S89.1 Other specified injuries of lower leg	0.002	0.998	0.000
S89.0 Multiple injuries of lower leg	0.002	0.998	0.000
C67.6 Ureteric orifice	0.000	0.998	0.002
Z43.1 Attention to gastrostomy	0.002	0.998	0.000
S89.8 Other specified injuries of lower leg	0.002	0.998	0.000
B18.2 Chronic viral hepatitis C	0.002	0.998	0.000
C02.1 Border of tongue	0.002	0.998	0.000
Z88.3 Personal history of allergy to other anti-infective agents	0.000	0.998	0.002
M77.13 Lateral epicondylitis-Forearm	0.002	0.998	0.000
H74.3 Other acquired abnormalities of ear ossicles	0.002	0.998	0.000
S30.8 Other superficial injuries of abdomen, lower back and pelvis	0.000	0.998	0.002
B18.1 Chronic viral hepatitis B without delta-agent	0.002	0.998	0.000
Z49.0 Preparatory care for dialysis	0.000	0.998	0.002
O00.9 Ectopic pregnancy, unspecified	0.000	0.998	0.002
Z43.0 Attention to tracheostomy	0.002	0.998	0.000
U50 Level of care administered to neonates	0.001	0.998	0.000
U07 Emergency use of U07	0.001	0.998	0.000
U06 Emergency use of U06	0.001	0.998	0.000
U04 Severe acute respiratory syndrome [SARS]	0.001	0.998	0.000
U52 First in a series of a regular day/night admissions	0.001	0.998	0.000
M54.47 Lumbago with sciatica (Lumbosacral region)	0.002	0.998	0.000
M77.19 Lateral epicondylitis (Site unspecified)	0.001	0.998	0.000
M77.18 Lateral epicondylitis-Other	0.001	0.998	0.000
M77.17 Lateral epicondylitis-Ankle/Foot	0.001	0.998	0.000
M77.16 Lateral epicondylitis (Lower leg)	0.001	0.998	0.000
M77.15 Lateral epicondylitis (Pelvic region and thigh)	0.001	0.998	0.000
M77.14 Lateral epicondylitis-Hand	0.001	0.998	0.000
M77.11 Lateral epicondylitis-Shldr region	0.001	0.998	0.000
M77.10 Lateral epicondylitis (Multiple sites)	0.001	0.998	0.000
C91.1 Chronic lymphocytic leukaemia	0.002	0.998	0.000
F52.9 Unspecified sexual dysfunction, not caused by organic disorder or disease	0.001	0.998	0.000
F52.8 Other sexual dysfunction, not caused by organic disorder or disease	0.001	0.998	0.000
F52.7 Excessive sexual drive	0.001	0.998	0.000
F52.6 Nonorganic dyspareunia	0.001	0.998	0.000
F52.5 Nonorganic vaginismus	0.001	0.998	0.000
F52.4 Premature ejaculation	0.001	0.998	0.000
F52.3 Orgasmic dysfunction	0.001	0.998	0.000
F52.1 Sexual aversion and lack of sexual enjoyment	0.001	0.998	0.000
H00 Hordeolum and chalazion	0.000	0.998	0.002
M62.81 Other specified disorders of muscle (Shoulder region)	0.000	0.998	0.002
R84.5 Abnormal microbiological findings	0.002	0.998	0.000
Z32.1 Pregnancy confirmed	0.000	0.998	0.002
Y45.8 Other analgesics and antipyretics	0.001	0.998	0.000
I62.9 Intracranial haemorrhage (nontraumatic), unspecified	0.001	0.998	0.000
N45.9 Orchitis, epididymitis and epididymo-orchitis without abscess	0.000	0.999	0.001
O81.3 Other and unspecified forceps delivery	0.001	0.999	0.000
F99 Mental disorder, not otherwise specified	0.001	0.999	0.000
U81 Agent resistant to vancomycin and related antibiotics	0.001	0.999	0.000
M79.10 Myalgia (Multiple sites)	0.001	0.999	0.000
F52.0 Lack or loss of sexual desire	0.001	0.999	0.000
G83.4 Cauda equina syndrome	0.000	0.999	0.001
K26.7 Chronic without haemorrhage or perforation	0.000	0.999	0.001
E34.9 Endocrine disorder, unspecified	0.001	0.999	0.000
H43.3 Other vitreous opacities	0.001	0.999	0.000
L03.0 Cellulitis of finger and toe	0.000	0.999	0.001
N71.1 Chronic inflammatory disease of uterus	0.001	0.999	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.001	0.999	0.000
H61.3 Acquired stenosis of external ear canal	0.001	0.999	0.000
S00.0 Superficial injury of scalp	0.001	0.999	0.000
U04.9 Severe acute respiratory syndrome [SARS], unspecified	0.001	0.999	0.000
U06.9 Emergency use of U06.9	0.001	0.999	0.000
U06.8 Emergency use of U06.8	0.001	0.999	0.000
U06.7 Emergency use of U06.7	0.001	0.999	0.000
U06.6 Emergency use of U06.6	0.001	0.999	0.000
U06.5 Emergency use of U06.5	0.001	0.999	0.000
U06.4 Emergency use of U06.4	0.001	0.999	0.000
U06.3 Emergency use of U06.3	0.001	0.999	0.000
U06.2 Emergency use of U06.2	0.001	0.999	0.000
U06.1 Emergency use of U06.1	0.001	0.999	0.000
U06.0 Emergency use of U06.0	0.001	0.999	0.000
U07.9 Emergency use of U07.9	0.001	0.999	0.000
U07.8 Emergency use of U07.8	0.001	0.999	0.000
U07.7 Emergency use of U07.7	0.001	0.999	0.000
U07.6 Emergency use of U07.6	0.001	0.999	0.000
U07.5 Emergency use of U07.5	0.001	0.999	0.000
U07.4 Emergency use of U07.4	0.001	0.999	0.000
U07.3 Emergency use of U07.3	0.001	0.999	0.000
U07.2 Emergency use of U07.2	0.001	0.999	0.000
U07.1 Emergency use of U07.1	0.001	0.999	0.000
U07.0 Emergency use of U07.0	0.001	0.999	0.000
U50.9 Inquest Adjourned Death	0.001	0.999	0.000
U50.3 Level of care administered to neonates (Maximal Intensive Care)	0.001	0.999	0.000
U50.2 Level of care administered to neonates (High Dependancy Intensive Care)	0.001	0.999	0.000
U50.1 Level of care administered to neonates (Special Care)	0.001	0.999	0.000
U50.0 Level of care administered to neonates (Normal Care)	0.001	0.999	0.000
D51.9 Vitamin B12 deficiency anaemia, unspecified	0.001	0.999	0.000
B18 Chronic viral hepatitis	0.001	0.999	0.000
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.000	0.999	0.001
I84.3 External thrombosed haemorrhoids	0.000	0.999	0.001
V23.4 Driver injured in traffic accident	0.000	0.999	0.001
Z51.1 Chemotherapy session for neoplasm	0.001	0.999	0.000
J39 Other diseases of upper respiratory tract	0.001	0.999	0.000
S36.10 Injury of liver or gallbladder (without open wound into cavity)	0.000	0.999	0.001
M62.82 Other specified disorders of muscle (Upper arm)	0.000	0.999	0.001
J39.0 Retropharyngeal and parapharyngeal abscess	0.001	0.999	0.000
N45.0 Orchitis, epididymitis and epididymo-orchitis with abscess	0.000	0.999	0.001
U81.8 Agent resistant to other vancomycin-related antibiotic	0.001	0.999	0.000
M65.91 Synovitis and tenosynovitis, unspecified (Shoulder region)	0.001	0.999	0.000
Q38.7 Pharyngeal pouch	0.000	0.999	0.001
B18.8 Other chronic viral hepatitis	0.001	0.999	0.000
B18.0 Chronic viral hepatitis B with delta-agent	0.001	0.999	0.000
D10.4 Tonsil	0.000	0.999	0.001
D10.1 Tongue	0.000	0.999	0.001
M62.8 Other specified disorders of muscle	0.000	0.999	0.001
G50.0 Trigeminal neuralgia	0.001	0.999	0.000
M21.5 Acquired clawhand, clubhand, clawfoot and clubfoot	0.001	0.999	0.000
V29.3 Motorcycle rider [any] injured in unspecified nontraffic accident	0.000	0.999	0.001
L50 Urticaria	0.001	0.999	0.000
M62.89 Other specified disorders of muscle (Site unspecified)	0.000	0.999	0.001
B18.9 Chronic viral hepatitis, unspecified	0.001	0.999	0.000
E87.1 Hypo-osmolality and hyponatraemia	0.001	0.999	0.000
J39.3 Upper respiratory tract hypersensitivity reaction, site unspecified	0.001	0.999	0.000
V23.5 Passenger injured in traffic accident	0.000	0.999	0.001
J95.0 Tracheostomy malfunction	0.001	0.999	0.000
G96 Other disorders of central nervous system	0.001	0.999	0.000
M23.32 Other meniscus derangements (Posterior cruciate ligament or Posterior horn of medial meniscus)	0.000	0.999	0.001
G37.9 Demyelinating disease of central nervous system, unspecified	0.000	0.999	0.001
M62.87 Other specified disorders of muscle (Ankle and foot)	0.000	0.999	0.001
M77.02 Medial epicondylitis (Upper arm)	0.001	0.999	0.000
C41.9 Bone and articular cartilage, unspecified	0.001	0.999	0.000
D80.1 Nonfamilial hypogammaglobulinaemia	0.000	0.999	0.001
H57.9 Disorder of eye and adnexa, unspecified	0.000	0.999	0.001
J15.7 Pneumonia due to Mycoplasma pneumoniae	0.001	0.999	0.000
S49.9 Unspecified injury of shoulder and upper arm	0.001	0.999	0.000
Z01.5 Diagnostic skin and sensitisation tests	0.001	0.999	0.000
M21.59 Acquired clawhand, clubhand, clawfoot and clubfoot-Site uns	0.001	0.999	0.000
M21.58 Acquired clawhand, clubhand, clawfoot and clubfoot-Other	0.001	0.999	0.000
M21.56 Acquired clawhand, clubhand, clawfoot and clubfoot-Lower le	0.001	0.999	0.000
M21.55 Acquired clawhand, clubhand, clawfoot and clubfoot-Pelvic/t	0.001	0.999	0.000
M21.53 Acquired clawhand, clubhand, clawfoot and clubfoot-Forearm	0.001	0.999	0.000
M21.52 Acquired clawhand, clubhand, clawfoot and clubfoot-Upper ar	0.001	0.999	0.000
M21.51 Acquired clawhand, clubhand, clawfoot and clubfoot-Shldr re	0.001	0.999	0.000
M21.50 Acquired clawhand, clubhand, clawfoot and clubfoot (Multiple sites)	0.001	0.999	0.000
C02.2 Ventral surface of tongue	0.001	0.999	0.000
C22.9 Liver, unspecified	0.001	0.999	0.000
L50.6 Contact urticaria	0.001	0.999	0.000
L50.5 Cholinergic urticaria	0.001	0.999	0.000
L50.4 Vibratory urticaria	0.001	0.999	0.000
L50.3 Dermatographic urticaria	0.001	0.999	0.000
L50.2 Urticaria due to cold and heat	0.001	0.999	0.000
U81.0 Vancomycin resistant agent	0.001	0.999	0.000
H58 Other disorders of eye and adnexa in diseases classified elsewhere	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations